$18.22
0.191.05%
At close: Aug 31, 5:00 PM EST
$18.22
N/A
After Hours: 4:00 PM EST

Janux Therapeutics (JANX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.28 | $-0.52 | $-0.64 | $-0.61 |
| Actual | $-0.35 | $-0.39 | $-0.51 | $-0.39 |
| Surprise | -25.0% | +25.0% | +20.3% | +36.1% |
| Revenue | ||||
| Estimate | $21.8M | $6.8M | $71430 | $5.0M |
| Actual | $10.3M | $3.7M | $0 | $10.0M |
| Surprise | -52.8% | -44.7% | -100.0% | +101.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.49 | $-0.57 | $-0.58 | $-0.61 |
| Revenue | ||||
| Consensus | $6.5M | $7.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.35 | $-0.28 | -25.0 % |
| Q1 | May 7, 2026 | $-0.39 | $-0.52 | 25.0 % |
| Q4 | Feb 26, 2026 | $-0.51 | $-0.64 | 20.3 % |
| Q3 | Nov 6, 2025 | $-0.39 | $-0.61 | 36.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $10.27M | $21.77M | -52.8 % |
| Q1 | May 7, 2026 | $3.73M | $6.75M | -44.7 % |
| Q4 | Feb 26, 2026 | $0 | $71.43K | -100.0 % |
| Q3 | Nov 6, 2025 | $10.00M | $4.97M | 101.3 % |